OFIX - Orthofix Medical Inc.
NEXT EARNINGS:
May 12, 2026
EPS Est: $-0.65
|
Rev Est: $202.3M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$20.00
DETAILS
HIGH:
$22.00
LOW:
$18.00
MEDIAN:
$20.00
CONSENSUS:
$20.00
UPSIDE:
56.86%
Market Cap:
504.90M
Volume:
660,852
Avg Volume:
205,891
52 Week Range:
10.24-20.48
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.76
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
1,616
IPO Date:
1992-04-24
EPS (TTM):
N/A
P/E Ratio:
N/A
Revenue (TTM):
N/A
Total Assets:
279.04M
Total Debt:
N/A
Cash & Equiv:
N/A
Rev Growth (5Y):
11.7%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-10.2%
ROCE:
N/A
Debt/Equity:
0.36
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-24 | $-0.06 | $0.44 | -112.6% | $219.9M | $200.4M | +9.8% |
| 2025-11-04 | $0.20 | $0.12 | +66.7% | $205.6M | $200.0M | +2.8% |
| 2025-08-05 | $0.13 | $0.04 | +225.0% | $203.1M | $201.1M | +1.0% |
| 2025-05-06 | $-0.08 | $-0.17 | +52.9% | $193.6M | $204.2M | -5.2% |
| 2025-02-25 | $0.02 | $0.06 | -66.7% | $215.7M | $199.7M | +8.0% |
| 2024-11-07 | $0.07 | $-0.14 | +150.0% | $196.6M | $212.8M | -7.6% |
| 2024-08-06 | $0.05 | $-0.13 | +138.5% | $198.6M | $195.2M | +1.7% |
| 2024-05-07 | $-0.46 | $-0.32 | -43.8% | $188.6M | $184.1M | +2.4% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 799.49M | 746.64M | 460.71M | 464.48M | 406.56M | 459.95M | 453.04M | 433.82M | 409.79M | 396.49M | 402.28M |
| Net Income | (90.81M) | (126.00M) | (151.40M) | (19.75M) | (38.38M) | 2.52M | (28.46M) | 13.81M | 6.22M | 3.06M | (2.81M) | (8.54M) |
| EPS | 0.00 | -3.30 | -4.12 | -0.98 | -1.95 | 0.13 | -1.51 | 0.75 | 0.34 | 0.17 | -0.15 | -0.46 |
| Total Assets | 279.04M | 893.29M | 925.32M | 458.63M | 476.62M | 525.86M | 495.62M | 466.64M | 405.35M | 372.10M | 400.22M | 393.19M |
| Total Debt | 0 | 179.63M | 117.07M | 21.53M | 24.31M | 24.94M | 22.85M | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 0 | 83.24M | 33.11M | 50.70M | 87.85M | 96.29M | 69.72M | 69.62M | 81.16M | 39.57M | 63.66M | 36.81M |
| Operating Cash Flow | 33.35M | 25.79M | (45.75M) | (11.54M) | 18.48M | 74.27M | 32.03M | 49.92M | 53.34M | 44.71M | 43.22M | 50.96M |
| Free Cash Flow | 33.35M | (9.09M) | (107.80M) | (34.70M) | (1.12M) | 57.18M | 11.51M | 34.66M | 36.39M | 26.37M | 15.32M | 32.43M |
| FCF per Share | N/A | -0.24 | -2.94 | -1.73 | -0.06 | 2.97 | 0.61 | 1.87 | 2.01 | 1.45 | 0.82 | 1.76 |
| Book Value | 0 | 503.12M | 598.73M | 336.86M | 336.93M | 356.86M | 327.63M | 335.40M | 296.61M | 263.48M | 290.31M | 299.63M |
| Cash & ST Investments | 0 | 83.24M | 33.11M | 50.70M | 87.85M | 96.29M | 69.72M | 69.62M | 81.16M | 39.57M | 63.66M | 36.81M |
| ROC Equity | N/A | -0.25 | -0.25 | -0.06 | -0.11 | 0.01 | -0.09 | 0.04 | 0.02 | 0.01 | -0.01 | -0.03 |